Publications

Stewart, M. T., Daily, S. M., Thomas, C. P., Panas, L., Ritter, G., & Reif, S. (2024). Expanding access to medication treatment for opioid use disorders: Findings from the Washington State hub and spoke effort. Drug and Alcohol Dependence, 256, 111125

Huskamp, H. A., Uscher-Pines, L., Raja, P., Normand, S.-L. T., Mehrotra, A., & Busch, A. B. (2024). Trends in Use of Telemedicine for Stimulant Initiation Among Children and Adults. Psychiatric Services

Barnett, M. L., Meara, E., Lewinson, T., Hardy, B., Chyn, D., Onsando, M., Huskamp, H. A., Mehrotra, A., & Morden, N. E. (2023). Racial Inequality in Receipt of Medications for Opioid Use Disorder. The New England Journal of Medicine, 388(19), 1779–1789.

Barsky, B., Mehrotra, A., & Huskamp, H. A. (2023). State policies could impede new efforts to increase access to medications for opioid use disorder. JAMA Health Forum, 4(3), e230071.

Busch, A. B., Kennedy-Hendricks, A., Schilling, C., Stuart, E. A., Hollander, M., Meiselbach, M. K., Barry, C. L., Huskamp, H. A., & Eisenberg, M. D. (2023). Measurement Approaches to Estimating Methadone Continuity in Opioid Use Disorder Care. Medical Care, 61(5), 314–320.

Busch, A. B., Mehrotra, A., Greenfield, S. F., Uscher-Pines, L., Rose, S., & Huskamp, H. A. (2023). A cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 144, 108920.

Hailu, R., Mehrotra, A., Huskamp, H. A., Busch, A. B., & Barnett, M. L. (2023). Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic. JAMA Network Open, 6(1), e2252381.

Huskamp, H. A., Riedel, L., Campa, I., Busch, A. B., Rose, S., Mehrotra, A., & Uscher-Pines, L. (2023). Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians. Journal of General Internal Medicine, 38(9), 2139–2146.

Hyland, C. J., McDowell, M. J., Bain, P. A., Huskamp, H. A., & Busch, A. B. (2023). Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review. Journal of Substance Abuse Treatment, 144, 108919.

Kennedy-Hendricks, A., Eddelbuettel, J. C. P., Bicket, M. C., Meiselbach, M. K., Hollander, M. A. G., Busch, A. B., Huskamp, H. A., Stuart, E. A., Barry, C. L., & Eisenberg, M. D. (2023). Impact of High Deductible Health Plans on U.S. Adults With Chronic Pain. American Journal of Preventive Medicine, 65(5), 800–808.

Uscher-Pines, L., Riedel, L. E., Mehrotra, A., Rose, S., Busch, A. B., & Huskamp, H. A. (2023). Many Clinicians Implement Digital Equity Strategies To Treat Opioid Use Disorder. Health Affairs (Project Hope), 42(2), 182–186.

Sousa, J. L., Raja, P., Huskamp, H. A., Mehrotra, A., Busch, A. B., Barnett, M. L., & Uscher-Pines, L. (2022). Perspectives of patients receiving telemedicine services for opioid use disorder treatment: A qualitative analysis of user experiences. J Addict Med, 16(6), 702-708.

Patel, S. Y., Ortiz, E. G., Barsky, B. A., Huskamp, H. A., Busch, A. B., & Mehrotra, A. (2022). Patient and clinician characteristics associated with use of telemedicine for buprenorphine induction among Medicare beneficiaries. J Gen Intern Med, 37(14), 3758-3761.

Reif, S., Brolin, M., Beyene, T. M., D'Agostino, N., Stewart, M. T., & Horgan, C. M. (2022). Payment and financing for substance use Screening and Brief Intervention for adolescents and adults in health, school, and community settings.  J Adolesc Health, 71(4S), S73-S82.

O'Brien, P. L., Stewart, M. T., Shields, M. C., White, M., Dubenitz, J., Dey, J., & Mulvaney-Day, N. (2022). Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field. Drug Alcohol Depend Rep, 4.

Richard, J. V., Huskamp, H. A., Barnett, M. L., Busch, A. B., & Mehrotra, A. (2022). A methodology for identifying behavioral health advanced practice registered nurses in administrative claims. Health Serv Res, 57(4), 973-978.

Frank, R. G. (2022). What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis. Addiction, 117(5), 1198-1199.

Schilling, C. J., Eisenberg, M. D., Kennedy-Hendricks, A., Busch, A. B., Huskamp, H. A., Stuart, E. A., Meiselbach, M. K., & Barry, C. L. (2022). Effects of high-deductible health plans on enrollees with mental health conditions with and without substance use disorders. Psychiatr Serv, 73(5), 518-525.

Patel, S. Y., Ortiz, E. G., Barsky, B. A., Huskamp, H. A., Busch, A. B., & Mehrotra, A. (2022). Patient and clinician characteristics associated with use of telemedicine for Buprenorphine induction among Medicare beneficiaries. J Gen Intern Med, 37(14), 3758-3761.

Barsky, B. A., Busch, A. B., Patel, S. Y., Mehrotra, A., & Huskamp, H. A. (2022). Use of telemedicine for Buprenorphine inductions in patients with commercial insurance or Medicare advantage. JAMA Netw Open, 5(1), e2142531.

Huskamp, H. A., Riedel, L., Uscher-Pines, L., Busch, A. B., Barnett, M. L., Raja, P., & Mehrotra, A. (2022). Initiating opioid use disorder medication via telemedicine during COVID-19: Implications for proposed reforms to the Ryan Haight Act. J Gen Intern Med, 37(1), 162-167.

Reif S, Stewart MT, Torres ME, Davis MT, Mohr B, Ritter GA. (2021) Effectiveness of value-based purchasing for substance use treatment engagement and retention. JSAT 122:(2021) 108217

Sabety AH, Sherry TB, Maestas N. Opioid use in older adults and Medicare Part D. Health Serv Res. 2021; 00: 1– 10. 

Busch AB, Sugarman DE, Horvitz LE, Greenfield SF, Telemedicine for treating mental health and substance use disorders: reflections since the pandemic. Neuropsychopharmacology. (2021). 

Busch AB, Greenfield SF, Reif S, Normand SLT, Huskamp HA. 2020. Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment. Journal of Substance Abuse Treatment, p.108040.

Shields MC, Ritter G, Busch AB, 2020. Electronic Health Information Exchange At Discharge From Inpatient Psychiatric Care In Acute Care Hospitals: Study examines the percentage of inpatient psychiatric units that reported using an electronic health record for health information exchange at transfers of care. Health Affairs, 39(6), pp.958-967.

Hodgkin D, Garnick DW, Horgan CM, Busch AB, Stewart MT, Reif S, 2020. Is it feasible to pay specialty substance use disorder treatment programs based on patient outcomes?. Drug and Alcohol Dependence, 206, p.107735.

Hodgkin D, Gao W, Larson MJ, Drebing CE, Merrick EL, Pugatch M, Horgan CM, Zolotusky G, Petry NM, Saitz R., 2020. Referral to Treatment After Positive Screens for Unhealthy Drug Use in an Outpatient Veterans Administration Setting. Journal of Addiction Medicine, 14(3), pp.236-243.

Reif S, Brolin MF, Stewart MT, Fuchs TJ, Speaker E, Mazel SB. 2020. The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders. Journal of substance abuse treatment, 108, pp.33-39.

Hodgkin D, Moscarelli M, Rupp A, Zuvekas SH. 2020. Mental health economics: bridging research, practice and policy. World Psychiatry, 19(2), p.258.

Yang J, Landrum MB, Zhou L, Busch AB. Disparities in outpatient visits for mental health and/or substance use disorders during the COVID surge and partial reopening in Massachusetts. Gen Hosp Psychiatry. 2020;67:100-106.

Huskamp HA, Busch AB, Uscher-Pines L, Barnett ML, Riedel L, Mehrotra A. Treatment of opioid use disorder among commercially insured patients in the context of the COVID-19 pandemic. JAMA. 2020 Dec 15;324(23):2440-2442. 

Hukamp HA, Reif S, Greenfield SF, Norman SL, Busch AB. Medication utilization for alcohol use disorder in a commercially insured population. Journal of internal medicine. 2020 Nov;35(11):3262-3270.

Davis MT, Torres M, Nguyen A, Stewart M, Reif S. (2019). Improving quality and performance in substance use treatment programs: What is being done and why is it so hard?. Journal of Social Work, 1468017319867834.

Hodgkin D, Garnick DW, Horgann CM, Busch AB, Stewart MT, Reif S. (2019). Is it feasible to pay specialty substance use disorder treatment programs based on patient outcomes?. Drug and Alcohol Dependence, 107735.

Hodgkin D, Gao W, Larson MJ, Drebing CE, Merrick EL, Pugatch M, Saitz R. (2019). Referral to Treatment After Positive Screens for Unhealthy Drug Use in an Outpatient Veterans Administration Setting. Journal of Addiction Medicine.

Garnick D, Horgan C, Mark TL, Lee M, Acevedo A, Neager S, Miller K. (2019). The importance of identification when measuring performance in addiction treatment. Substance Abuse, 1-5.

Miles J. (2019). Changes in Residential Substance Use Treatment Service Access Resulting from Recent Medicaid Section 1115 Waivers. Psychiatric Services, appi-ps.

Acevedo A, Miles J, Garnick DW, Panas L, Ritter GA, Campbell K, Acevedo-Garcia D. (2018). Employment after Beginning Treatment for Substance Use Disorders: The Impact of Race/Ethnicity and Client Community of Residence. Journal of Substance Abuse Treatment, 87, 31-41.

Acevedo A, Panas L, Garnick DW, Acevedo-Garcia D, Miles J, Ritter GA, Campbell K. (2018). Disparities in the Treatment of Substance Use Disorders: Does Where You Live Matter? The Journal for Behavioral Health Services and Research, 45(4), 533-549.  

Busch AB, Bates DW, Rauch SL. (2018). Improving Adoption of EHRs in Psychiatric Care. The New England Journal of Medicine, 378(18), 1665-1667.

Donohue JM, Barry CL, Stuart EA, Greenfield SF, Song Z, Chernew ME, and Huskamp HA. (2018). Effects of Global Payment and Accountable Care on Medication Treatment for Alcohol and Opioid Use Disorders. Journal of Addiction Medicine, 12(10), 11-18.

Hodgkin D, Connery HS. (2018). Effectiveness and Availability of Treatment for Substance Use Disorders. In Oxford Research Encyclopedia of Economics and Finance. Oxford, U.K.: Oxford University Press.

Hodgkin D, Horgan CM, Stewart MT, Quinn AE, Creedon TB, Reif S, Garnick DW. (2018).  Federal Parity and Access to Behavioral Health Care in Private Health Plans. Psychiatric Services, 69(4), 396-402.

Huskamp HA, Busch AB, Souza J, Uscher-Pines L, Rose S, Wilcock A, Landon BE, Mehrota A. (2018). How is Telemedicine Being Used for Opioid and Other Substance Use Disorders? Health Affairs, 37(12), 1340-1347.

Huskamp HA, Riedel LE, Barry CL, Busch AB. (2018). Coverage of Medications that Treat Opioid Use Disorder and Opioids for Pain Management in Marketplace Plans, 2017. Medical Care, 56(6), 505-509.

Lee MT, Acevedo A, Garnick DW, Horgan CM, Panas L, Ritter GA, Campbell K. (2018). Impact of Agency Receipt of Incentives and Reminders on Engagement and Continuity of Care for Clients with Co-occurring Disorders. Psychiatric Services, 69(7), 804-811.

McDowell MJ, Busch AB, Sen AP, Stuart EA, Riedel L, Barry CL, Huskamp HA. (2018). Participation in Accountable Care Organizations among Hospitals Offering Substance Use Disorder and Mental Health Services. Psychiatric Services, 69(11), 1131-1134.

Stewart MT, Reif S, Dana B, Nguyen A, Torres M, Davis, MT, Horgan CM. (2018). Incentives in a Public Addiction Treatment System: Effects on Waiting Time and Selection. Journal of Substance Abuse Treatment, 95, 1-8.

Berry K.N., Huskamp H.A., Goldman H.H., Rutkow L., and Barry, C.L. (2017). Litigation Provides Clues to Ongoing Challenges in Implementing Insurance Parity. Journal of Health Politics, Policy and Law, 42(6), 1065-1098.

Garnick, D.W., Horgan, C.M., Acevedo, A., Lee, M.T., Panas, L., Ritter, G.A, Campbell, K., and Bean-Mortinson, J. (2017). Influencing Quality of Outpatient SUD Care: Implementation of Alerts and Incentives in Washington State. Journal of Substance Abuse Treatment, 82, 93-101.

Garnick, D.W., Horgan, C.M., Merrick, E.L., Hodgkin, D., Reif, S., Quinn, A.E., Stewart, M.T., and Creedon, T.B. (2017). Private Health Plans’ Contracts with Managed Behavioral Healthcare Organizations. Journal of Behavioral Health Services and Research, 44(1), 149–157.

Hodgkin, D., Reif, S., Stewart, M.T., Mohr, B., and Horgan, C.M. (2017). Target Attainability and Provider Response in Pay-For-Performance: Evidence from Substance Use Disorder Treatment. Journal of Mental Health Policy and Economics, 20, S15-S15.

Joyce, N.R., Huskamp, H.A., Hadland, S.E., Donohue, J.M., Greenfield, S.F., Stuart, E.A., and Barry, C.L. (2017). The Alternative Quality Contract: Impact on Service Use and Spending for Children with ADHD. Psychiatric Services, 68(12), 1210-1212.

Quinn, A.E., Hodgkin, D., Perloff, J.N., Stewart, M.T., Brolin, M., Lane, N.E., and Horgan, C.M. (2017). Design and Impact of Bundled Payment for Detox and Follow-up Care. Journal of Substance Abuse Treatment, 82, 113-121.

Quinn, A.E., Reif, S., Merrick, E.L., Horgan, C.M., Garnick, D.W., and Stewart, M.T. (2017). How Do Private Health Plans Manage Specialty Behavioral Health Treatment Entry and Continuing Care? Psychiatric Services, 68(9), 931-937.

Quinn, A.E., Stewart, M.T., Brolin, M., Horgan, C.M., and Lane, N.E. (2017). Massachusetts Substance Use Disorder Treatment Organizations’ Perspectives on the Affordable Care Act: Changes in Payment, Services, and System Design. Journal of Psychoactive Drugs, 49(2), 151-159.

Reif, S., Acevedo, A., Garnick, D.W., and Fullerton, C.A. (2017). Reducing Behavioral Health Inpatient Readmissions for People with Substance Use Disorders: Do Follow-Up Services Matter? Psychiatric Services, 68(8), 810-818.

Reif, S., Creedon, T.B., Horgan, C.M., Stewart, M.T., and Garnick, D.W. (2017). Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014. Journal of Psychoactive Drugs, 49(2), 102-110.

Stewart, M.T., Horgan, C.M., Hodgkin, D., Creedon, T.B., Quinn, A.E., Garito, L., Reif, S., and Garnick, D.W. (2017). Behavioral Health Coverage under the Affordable Care Act: What Can We Learn from Marketplace Products? Psychiatric Services, 69(3), 315-321.

Stewart, M.T., Horgan, C.M., Quinn, A.E., Garnick, D.W., Reif, S., Creedon, T.B., and Merrick, E.L. (2017). The Role of Health Plans in Supporting Behavioral Health Integration. Administration and Policy in Mental Health and Mental Health Services Research, 44(6), 967-977.

Horgan, C.M., Stewart, M.T., Reif, S., Garnick, D.W., Hodgkin, D., Merrick, E.L., and Quinn, A.E. (2016). Behavioral Health Services in the Changing Landscape of Private Health Plans. Psychiatric Services, 67(6), 622-629.

Huskamp, H.A., and Iglehart, J.K. (2016). Mental Health and Substance-Use Reforms–Milestones Reached, Challenges Ahead. New England Journal of Medicine, 375, 688-695.

Mark, T.L., Hodgkin, D., Levit, K.R., and Thomas, C.P. (2016). Growth in Spending on and Use of Services for Mental and Substance Use Disorders after the Great Recession among Individuals With Private Insurance. Psychiatric Services, 67(5), 504-509.

Quinn, A.E., Brolin, M., Stewart, M.T., Evans, B., and Horgan, C.M. (2016, April). Reducing Risky Alcohol Use: What Health Care Systems Can Do. In Issue brief (Massachusetts Health Policy Forum) (No. 46, pp. 1-50).

Quinn, A.E., Reif, S., Evans, B., Creedon, T.B., Stewart, M.T., Garnick, D.W., and Horgan, C.M. (2016). How Health Plans Promote Health IT to Improve Behavioral Health Care. The American Journal of Managed Care, 22(12), 810-815.

Reif, S., Horgan, C.M., Hodgkin, D., Matteucci, A.M., Creedon, T.B., and Stewart, M.T. (2016). Access to Addiction Pharmacotherapy in Private Health Plans. Journal of Substance Abuse Treatment, 66, 23-29.

Acevedo, A., Garnick, D.W., Dunigan, R., Horgan, C.M., Ritter, G.A., Lee, M.T., ... and Leeper, T. (2015). Performance Measures and Racial/Ethnic Disparities in the Treatment of Substance Use Disorders. Journal of Studies on Alcohol and Drugs, 76(1), 57-67.

Acevedo, A., Garnick, D.W., Ritter, G.A., Horgan, C.M., and Lundgren, L. (2015). Race/Ethnicity and Quality Indicators for Outpatient Treatment for Substance Use Disorders. The American Journal on Addictions, 24(6), 523-531.

Brolin, M., Dennehy, K., Booxbaum, A., and Horgan, C.M. (2015, November). Improving Access to Substance Abuse Treatment and Reducing Incarceration and Recidivism. In Issue brief (Massachusetts Health Policy Forum) (No. 44, pp. 1-46).

Horgan, C.M., Hodgkin, D., Stewart, M.T., Quinn, A.E., Merrick, E.L., Reif, S., Garnick, D.W., and Creedon, T.B. (2015). Health Plans’ Early Response to Federal Parity Legislation for Mental Health and Addiction Services. Psychiatric Services, 67(2), 162-168.

Merrick, E.L., Hodgkin, D., Horgan, C.M., and Quinn, A.E. (2015). Employee Assistance Programs in Private Health Plans: What Do They Offer? Psychiatric Services, 66(3), 220-220.

Quinn, A.E., Horgan, C.M., Brolin, M., Stewart, M.T., Hodgkin, D., and Lane, N. (2015, December). Delivery and Payment Reform in Massachusetts: Substance Use Disorder Treatment Organizations’ Perspectives. Addiction Science and Clinical Practice, 10(S1), A51.

Uscher-Pines, L., Huskamp, H.A. and Mehrotra, A., 2020. Treating Patients With Opioid Use Disorder in Their Homes: An Emerging Treatment Model. JAMA.

Uscher-Pines, L., Raja, P., Qureshi, N., Huskamp, H.A., Busch, A.B. and Mehrotra, A., 2020. Use of Tele–mental Health in Conjunction With In-person Care: A Qualitative Exploration of Implementation Models. Psychiatric Services, 71(5), pp.419-426.

Acevedo, A., Lee, M.T., Garnick, D.W., Horgan, C.M., Ritter, G.A., Panas, L., Campbell, K., and Bean-Mortinson, J. (2017). Agency-Level Financial Incentives and Electronic Reminders to Improve Continuity of Care after Discharge from Residential Treatment and Detoxification. Drug and Alcohol Dependence, 183, 192-200.

Brolin, M., Torres, M., Hodgkin, D., Horgan, C.M., Lee, M., Merrick, E.L., ... and Gewirtz, A. (2017). Implementation of Client Incentives within a Recovery Navigation Program. Journal of Substance Abuse Treatment, 72, 25-31.

Johnson, J.K., Johnson, R.M., Hodgkin, D., Jones, A.A., Matteucci, A.M., and Harris, S.K. (2017). Heterogeneity of State Medical Marijuana Laws and Adolescent Recent Use of Alcohol and Marijuana: Analysis of 45 States, 1991–2011. Substance Abuse, 39(2), 1-8.

McGuire, T.G., and van Kleef, R.C. (2017). Introduction to the Special Section on Regulated Competition. Journal of Health Economics, 56, 234-236.

McGuire, T.G., and van Kleef, R.C. (2017). Risk Adjustment, Risk Sharing and Premium Regulation in Health Insurance Markets: Theory and Practice. New York: Elsevier Publishing.

Stuart, E.A., Barry, C.L., Donohue, J.M., Greenfield, S.F., Duckworth, K., Song, Z., ... and Huskamp, H.A. (2017). Effects of Accountable Care and Payment Reform on Substance Use Disorder Treatment: Evidence from the Initial 3 Years of the Alternative Quality Contract. Addiction, 112(1), 124-133.

Acevedo, A., Garnick, D.W., Ritter, G.A., Lundgren, L., and Horgan, C.M. (2016). Admissions to Detoxification after Treatment: Does Engagement Make a Difference? Substance Abuse, 37(2), 364-371.

Adams, R.S., Larson, M.J., Corrigan, J.D., Ritter, G.A., Horgan, C.M., Bray, R.M., and Williams, T.V. (2016). Combat-Acquired Traumatic Brain Injury, Posttraumatic Stress Disorder, and Their Relative Associations with Postdeployment Binge Drinking. The Journal of Head Trauma Rehabilitation, 31(1), 13-22.

Huskamp, H.A., Greenfield, S.F., Stuart, E.A., Donohue, J.M., Duckworth, K., Kouri, E.M., ... and Barry, C.L. (2016). Effects of Global Payment and Accountable Care on Tobacco Cessation Service Use: An Observational Study. Journal of General Internal Medicine, 31(10), 1134-1140.

Creedon, T.B., Quinn, A.E., Liu, X., Hodgkin, D., and Horgan, C.M. (2015). Availability of Outpatient Methadone Maintenance. Addiction Science and Clinical Practice, 10(S1), A8.